Interferon-induced factor 16 is essential in metastatic melanoma to maintain STING levels and the immune responses upon IFN-{gamma} response pathway activation
Background
Immune checkpoint inhibitor (ICIs)-based therapies are the standard of care treatment for patients with metastatic melanoma (MM). The stimulator of interferon genes (STING) signaling pathway is critical in controlling immune responses to IC…